Results 91 to 100 of about 11,369 (213)
Supplementary Figure from NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy
, 2022 Supplementary Figure from NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor ...John D. Heiss (15038744), Guangsheng Pei (15038747), Samantha Chao (15020841), Toshihiko Shimizu (1656517), E. Antonio Chiocca (8669859), Kimberly Rivera-Caraballo (15038735), Zhongming Zhao (12534149), Joseph C. Glorioso (14907336), Jin Muk Kang (14919360), Hiroshi Nakashima (327194), Jessica Swanner (15038729), Michael A. Caligiuri (11252657), Cole T. Lewis (15038726), Bangxing Hong (121392), Yoshihiro Otani (8675166), Sara A. Murphy (15038732), Yeshavanth Banasavadi-Siddegowda (15038741), Jianhua Yu (283600), Ji Young Yoo (15038723), Sean E. Lawler (15038738), Balveen Kaur (14941806), Yuanqing Yan (316563) +21 morecore +1 more sourceCinnamaldehyde From Cinnamon as a Food‐Derived Bioactive: Phytochemistry, Anticancer Mechanisms, Bioavailability, Nanoformulation and Safety
Food Frontiers, Volume 7, Issue 5, September 2026.Cinnamaldehyde derived from Cinnamomum species exerts multitarget anticancer effects by promoting oxidative stress, mitochondrial dysfunction, apoptosis, cell‐cycle arrest, autophagy, and epigenetic changes, and by suppressing mitogen‐activated protein kinase (MAPK), phosphoinositide 3‐kinase/protein kinase B/mechanistic target of rapamycin (PI3K/Akt ...Gervason Moriasi, Sally Kamau, Gulnaz Seitimova, Shynar Zhumagaliyeva, Javad Sharifi‐Rad, William N. Setzer, Daniela Calina +6 morewiley +1 more sourceSupplementary Figure 2 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
, 2010 Supplementary Figure 2 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid ...Yasuo Urata (157765), Noriaki Tanaka (8478), Ryo Sakai (751281), Yuuri Hashimoto (157732), Toshiyoshi Fujiwara (157767), Shunsuke Kagawa (157766), Toru Kojima (157751), Yuichi Watanabe (157757), Yasumoto Yamasaki (14904660), Futoshi Uno (157760) +9 morecore +1 more sourceIntegrated Engineering of CAR‐T Cells for Solid Tumours
Cell Proliferation, Volume 59, Issue 9, September 2026.Solid tumours pose multifactorial barriers including antigen heterogeneity, immunosuppressive microenvironment, and poor T‐cell trafficking, limiting CAR‐T efficacy compared to hematologic malignancies. Integrated engineering strategies are essential, combining logic‐gated receptors for precision, metabolic‐epigenetic reprogramming for resilience, and ...Chao Yang, Tan Li, Ping He, Zhijie Zhao, Shenglong Li, Liming Wang +5 morewiley +1 more sourceTUMOR-INTRINSIC AND PERIPHERAL FEATURES ASSOCIATE WITH SURVIVAL AFTER POLIO VIROTHERAPY IN RECURRENT GBM
, 2021 TUMOR-INTRINSIC AND PERIPHERAL FEATURES ASSOCIATE WITH SURVIVAL AFTER POLIO VIROTHERAPY IN RECURRENT ...Junfei Zhao (793606), Annick Desjardins (180835), Yeqing Chen (722741), Andrea Muscat (267150), Zhi Wei (258408), Nike Beaubier (10870812), Frances McSherry (13356630), Kevin Stevenson (8171262), Darell Bigner (6753434), Roel Verhaak (9621999), Smita Nair (289014), Roger McLendon (549823), Xiang Lin (525346), James Herndon (5313776), Gao Zhang (660886), Frederick Varn (3995063), David M Ashley (11461396), Allan Friedman (13356537), Mustafa Khasraw (13078896), Eric Lipp (13356513), John Sampson (13356534), Michael Brown (219384), Katherine Peters (13356522), Hai Yan (168017), Dina Randazzo (13356516), Matthias Gromeier (27798), Henry Friedman (13356540), Yiping He (168012) +27 morecore Supplementary Data from NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy
, 2022 Supplementary Data from NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor ...John D. Heiss (15038744), Guangsheng Pei (15038747), Samantha Chao (15020841), Toshihiko Shimizu (1656517), E. Antonio Chiocca (8669859), Kimberly Rivera-Caraballo (15038735), Zhongming Zhao (12534149), Joseph C. Glorioso (14907336), Jin Muk Kang (14919360), Hiroshi Nakashima (327194), Jessica Swanner (15038729), Michael A. Caligiuri (11252657), Cole T. Lewis (15038726), Bangxing Hong (121392), Yoshihiro Otani (8675166), Sara A. Murphy (15038732), Yeshavanth Banasavadi-Siddegowda (15038741), Jianhua Yu (283600), Ji Young Yoo (15038723), Sean E. Lawler (15038738), Balveen Kaur (14941806), Yuanqing Yan (316563) +21 morecore +1 more sourceMicrobiota–Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma
Brain and Behavior, Volume 16, Issue 8, August 2026.Microbiota–neuroinflammation crosstalk in GBM.
The schematic summarizes how gut microbiota and microbiota‐derived signals may influence GBM biology through gut–brain signaling, microbial metabolites, systemic immune modulation, BBB‐related pathways, tumor‐associated microbial signals, and immune‐metabolic changes within the GBM microenvironment.Tareq Nayef AlRamadneh, Renuka Jyothi S, Priya Priyadarshini Nayak, Anima Nanda, Shaker Al Hasnaawei, Akanksha Bhatt, Ashish Singh Chauhan, Siya Singla, Mehrdad Nourizadeh +8 morewiley +1 more sourceSupplementary Figure 1 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
, 2010 Supplementary Figure 1 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid ...Yasuo Urata (157765), Noriaki Tanaka (8478), Ryo Sakai (751281), Yuuri Hashimoto (157732), Toshiyoshi Fujiwara (157767), Shunsuke Kagawa (157766), Toru Kojima (157751), Yuichi Watanabe (157757), Yasumoto Yamasaki (14904660), Futoshi Uno (157760) +9 morecore +1 more source